Evidence map›Paper›PMID 25674260›Full record

ArticleInternational journal of clinical and experimental pathology2014

Chronic progressive external ophthalmoplegia with inflammatory myopathy.

Ting Chen, Chuanqiang Pu, Qiang Shi, Qian Wang, Lu Cong, Jiexiao Liu, Hongyu Luo, Lingna Fei, Wei Tang, Shanshan Yu

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Succinate Dehydrogenase B (SDHB) Immunohistochemistry for the Evaluation of Muscle Biopsies.Applied immunohistochemistry & molecular morphology : AIMM · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ting ChenDepartment of Neurology, Chinese PLA General Hospital 28 Fu Xing Road, Beijing 100853, China ; School of medicine, Nankai University 94 Weijing Road, Tianjin 300071, China.
Chuanqiang PuDepartment of Neurology, Chinese PLA General Hospital 28 Fu Xing Road, Beijing 100853, China ; School of medicine, Nankai University 94 Weijing Road, Tianjin 300071, China.
Qiang ShiDepartment of Neurology, Chinese PLA General Hospital 28 Fu Xing Road, Beijing 100853, China.
Qian WangDepartment of Emergency, Chinese Armed Police General Hospital 69 YongDing Road, Beijing 100039, China.
Lu CongDepartment of Neurology, Chinese PLA General Hospital 28 Fu Xing Road, Beijing 100853, China.
Jiexiao LiuDepartment of Neurology, Chinese PLA General Hospital 28 Fu Xing Road, Beijing 100853, China.
Hongyu LuoBGI-shenzhen Shenzhen 518083, China.
Lingna FeiBGI-shenzhen Shenzhen 518083, China.
Wei TangBGI-shenzhen Shenzhen 518083, China.
Shanshan YuBGI-shenzhen Shenzhen 518083, China.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic progressive external ophthalmoplegia is one of mitochondrial disorders, characterized by ptosis, limitation of eye movement, variably severe bulbar muscle weakness and proximal limb weakness. Chronic progressive external ophthalmoplegia complicated with acquired disease is extremely rare. We report a 44 years old male patient with more than 20 years of chronic progressive bilateral ptosis and limitation of eye movements manifested dysarthria, dysphagia and neck muscle weakness for 3 years. The first muscle biopsy showed red-ragged fibers and cytochrome c oxidase negative fibers as well as inflammatory cells infiltration. Electron microscopy revealed paracrystalline inclusions. Mitochondrial genetic analysis demonstrated a large-scale mtDNA deletion of m.8470_13446del4977. The patient was treated with prednisone. In a three-year follow-up study, the second biopsy was performed. Before the treatment, except bilateral ptosis and external ophthalmopelgia, this patient presented bulbar muscle weakness and neck muscle weakness. After treated with prednisone, the symptoms of dysphagia, dysarthria and neck muscle weakness were significantly improved, and the second biopsy showed only mitochondrial myopathy pathology but the inflammations disappeared. Here, we report a patient with chronic progressive external ophthalmoplegia complicated with inflammatory myopathy and after treated with prednisone as myositis, he had a significant therapeutic effect.

Indexed as

AdultAnti-Inflammatory AgentsHumansMaleMyositisOphthalmoplegia, Chronic Progressive ExternalPrednisoneAnti-Inflammatory AgentsPrednisoneChronic progressive external ophthalmoplegiainflammatory myopathymitochondrial DNA deletions

Identifiers

PMID25674260
PMCPMC4314000
OpenAlexW2397256336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.